🇰🇷 Venclexta in South Korea

Venclexta (venetoclax) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Venclexta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Venclexta approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Venclexta in South Korea?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.